|
LOC341056 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.026850E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.381900E-02 |
| Normal-vs-Stage2 |
8.573000E-01 |
| Normal-vs-Stage3 |
2.745800E-01 |
| Normal-vs-Stage4 |
2.472200E-02 |
| Stage1-vs-Stage2 |
1.558970E-01 |
| Stage1-vs-Stage3 |
6.539800E-01 |
| Stage1-vs-Stage4 |
2.346200E-01 |
| Stage2-vs-Stage3 |
4.142400E-01 |
| Stage2-vs-Stage4 |
6.489700E-02 |
| Stage3-vs-Stage4 |
2.149600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.682380E-01 |
| Normal-vs-AfricanAmerican |
3.78070000000008E-05 |
| Normal-vs-Asian |
7.446200E-01 |
| Caucasian-vs-AfricanAmerican |
1.036540E-04 |
| Caucasian-vs-Asian |
3.665600E-01 |
| AfricanAmerican-vs-Asian |
2.396700E-04 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.600780E-01 |
| Normal-vs-Female |
1.052570E-01 |
| Male-vs-Female |
9.322600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.471600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.850600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.327400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.478200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.396000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.538200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.428600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.717600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.158800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.845050E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.933400E-01 |
| Classical-VS-Follicular |
6.286000E-02 |
| Classical-VS-Other |
6.648400E-01 |
| Classical-VS-Normal |
6.832100E-02 |
| Tall-VS-Follicular |
3.392000E-01 |
| Tall-VS-Other |
5.895600E-01 |
| Tall-VS-Normal |
2.361600E-01 |
| Follicular-VS-Other |
3.299400E-01 |
| Follicular-VS-Normal |
8.007800E-01 |
| Other-VS-Normal |
2.379400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.947200E-01 |
| Normal-vs-N1 |
4.88509999996278E-06 |
| N0-vs-N1 |
3.0745000001442E-07 |
|
|
